| Financial Year |
March 31 2023 |
| Monetary Funds |
443,739,060.99 |
| Held-for-trading Financial Assets |
7,595,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
146,615,912.12 |
| Advances to Suppliers |
382,974,847.68 |
| Other Receivables |
10,529,395.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
77,898.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
93,960,442.25 |
| Total Current Assets |
1,085,492,557.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,478,303.85 |
| Investment Properties |
18,294,096.23 |
| Fixed Assetes |
138,917,235.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,310,598.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,618,763.51 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
276,650,518.18 |
| Total Assets |
1,362,143,075.53 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
66,629,889.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,102,700.05 |
| Taxes Payable |
2,336,076.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,771,197.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,638,810.78 |
| Other Current Liabilities |
13,941,593.96 |
| Sub-Total of Current Liabilities |
328,850,410.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
678,093.63 |
| Total Liabilities |
329,528,503.69 |
| Paid-In Capital(Or Share Stock) |
126,753,200.00 |
| Capital Surplus |
505,312,332.38 |
| Surplus Reserve |
27,941,787.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
356,675,667.50 |
| Minority Stockholder's Interest |
4,700,443.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,027,914,128.41 |
| Owner's Equity（Stockholder's Equity） |
1,032,614,571.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,362,143,075.53 |
